| 0 (0%) | 09-27 11:14 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term | |
|||
| Targets | 6-month : | 24.14 | 1-year : | 28.19 |
| Resists | First : | 20.67 | Second : | 24.14 |
| Pivot price | 20.1  |
|||
| Supports | First : | 19.65 | Second : | 19.02 |
| MAs | MA(5) : | 20.17 |
MA(20) : | 20.01 |
| MA(100) : | 17.96 |
MA(250) : | 16.84 |
|
| MACD | MACD : | 0.1 |
Signal : | 0.1 |
| %K %D | K(14,3) : | 59.9 |
D(3) : | 67.1 |
| RSI | RSI(14): 51.7 |
|||
| 52-week | High : | 20.96 | Low : | 13.46 |
Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.[ ERF ] has closed above bottom band by 48.2%. Bollinger Bands are 64% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 8 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 20.32 - 20.46 | 20.46 - 20.57 |
| Low: | 19.7 - 19.83 | 19.83 - 19.94 |
| Close: | 19.89 - 20.11 | 20.11 - 20.29 |
Wed, 24 Sep 2025
Exploring AP2/ERF Transcription Factors in Perennial Ryegrass - BIOENGINEER.ORG
Wed, 24 Sep 2025
Genome-wide analysis of the AP2/ERF transcription factor superfamily in perennial ryegrass - BMC Genomics
Wed, 24 Sep 2025
Is Eurofins Scientific (ENXTPA:ERF) Undervalued? A Fresh Look at Fair Value After Recent Trading Pause - Yahoo Finance
Wed, 17 Sep 2025
Art Studio ErF World Inks 15K-SF Lease at 94 Bogart Street in Brooklyn - Commercial Observer
Wed, 16 Jul 2025
First contact with greater gravity: Moss plants adapted via enhanced photosynthesis mediated by AP2/ERF transcription factors - Science | AAAS
Mon, 14 Jul 2025
Identification and Analysis of the AP2/ERF Gene Family in Barley Based on Pan-Genome and Pan-Transcriptome - ACS Publications
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 204 (M) |
| Shares Float | 201 (M) |
| Held by Insiders | 1.3 (%) |
| Held by Institutions | 67.9 (%) |
| Shares Short | 2,680 (K) |
| Shares Short P.Month | 2,220 (K) |
| EPS | 1.78 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 6.09 |
| Profit Margin | 26 % |
| Operating Margin | 23.6 % |
| Return on Assets (ttm) | 15.2 % |
| Return on Equity (ttm) | 32.2 % |
| Qtrly Rev. Growth | -13.2 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 7.24 |
| EBITDA (p.s.) | 4.25 |
| Qtrly Earnings Growth | -48.5 % |
| Operating Cash Flow | 825 (M) |
| Levered Free Cash Flow | 127 (M) |
| PE Ratio | 11.22 |
| PEG Ratio | 0 |
| Price to Book value | 3.29 |
| Price to Sales | 2.77 |
| Price to Cash Flow | 4.97 |
| Dividend | 0.09 |
| Forward Dividend | 0 |
| Dividend Yield | 0.4% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|